Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
HK Stock Market Move | METASPACEX (01796) fell more than 7% in early trading, and after resumption of trading, it opened at a low of over 45%. The agreement to sell the controlling shareholder's shares has been terminated.
HK Stock Market Move | DONGYUE GROUP (00189) rose more than 4%, hydrofluoric acid prices may see a significant increase, the supply and demand structure of the company's two major sectors has improved significantly.
HK Stock Market Move | Hua Hong Semi (01347) rose more than 3% after its performance, and the first quarter net profit attributable to shareholders increased by more than 4.58 times year-on-year. It is expected that the acquisition of Huahong Micro will be completed in the second half of the year.
HK Stock Market Move | METASPACEX (01796) fell more than 7% in early trading, and after resumption of trading, it opened at a low of over 45%. The agreement to sell the controlling shareholder's shares has been terminated.
HK Stock Market Move | DONGYUE GROUP (00189) rose more than 4%, hydrofluoric acid prices may see a significant increase, the supply and demand structure of the company's two major sectors has improved significantly.
HK Stock Market Move | Hua Hong Semi (01347) rose more than 3% after its performance, and the first quarter net profit attributable to shareholders increased by more than 4.58 times year-on-year. It is expected that the acquisition of Huahong Micro will be completed in the second half of the year.
